26 min listen
Cracking the U.S. Dry Eye Market, With Brent Jones, CCO, I-MED Pharma
Cracking the U.S. Dry Eye Market, With Brent Jones, CCO, I-MED Pharma
ratings:
Length:
23 minutes
Released:
Nov 30, 2021
Format:
Podcast episode
Description
When you’re an entrepreneur building out a company, it’s not enough to hire people with expertise you don’t have. As Brent Jones, Chief Operating Officer of I-MED Pharma, says in this week’s podcast, you have to ask questions and listen to what your experts have to say.I-MED Pharma, a Montreal, Quebec-based company that offers a complete portfolio of dry eye disease products, is the latest stop for Jones in a career that includes sales leadership roles at Grieshaber, Alcon Laboratories, Santen, ISTA Pharmaceuticals and Bausch + Lomb.He’ll apply everything he’s learned over the past 30 years to help I-MED enter the U.S. market in early 2022. The company’s blended portfolio includes the entire dry eye continuum—diagnostics, drops (including BAK free), ointments, plugs, nutrition and an intense regulated pulsed light (IRPL) device used to treat dry eye disease due to meibomian gland dysfunction.I-MED’s holistic product line allows for what Jones calls a consultative approach. He’s developing a sales force with deep product expertise, as well as implementation specialists, to provide information for physicians, training for their staff, and maintenance to I-MED devices when needed.Join the conversation with podcast host Ehsan Sadri, MD, of Visionary Eye Institute to learn:How Jones pivoted throughout his career between start-ups and large corporations.How I-MED Pharma plans to tackle the fragmented, competitive U.S. dry eye market with a physician-centered approach.Full details on the I-MED product line.Jones’s advice for emerging eye care entrepreneurs.
Released:
Nov 30, 2021
Format:
Podcast episode
Titles in the series (100)
Mazzo Muses on the FDA, Google and Failing Fast by OIS Podcast | Ophthalmology's leading Podcast